Therapeutic options for low bone mineral density in HIV-infected subjects.

about

Adverse bone health among children and adolescents growing up with HIV.HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.Ageing with HIV.People Living With HIV: Implications for Rehabilitation Nurses.

P2860

Q37098360-5150D12F-D8AF-490F-AA3F-51C8F6B60A19 Q38055705-5FF991D0-60C3-43C3-86B5-22E90B180701 Q50001938-F5D8E4FD-2BD0-4D0C-8B15-5B8C7ECC30D6 Q55492735-9AD87D92-2BA2-48F3-9649-A3C98F0EB3C5

P2860

Therapeutic options for low bone mineral density in HIV-infected subjects.

Item

http://www.wikidata.org/entity/Q38005045

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Therapeutic options for low bone mineral density in HIV-infected subjects.

@en

type

Item

label

Therapeutic options for low bone mineral density in HIV-infected subjects.

@en

prefLabel

Therapeutic options for low bone mineral density in HIV-infected subjects.

@en

P1476

Therapeutic options for low bone mineral density in HIV-infected subjects.

@en

P2093

Aoife G Cotter

http://www.w3.org/2001/XMLSchema#string

Patrick W G Mallon

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Denosumab in postmenopausal women with low bone mineral density

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Update in male osteoporosis.

Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis

Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

P2888

s11904-012-0117-9

P304

148-159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11904-012-0117-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22528765

http://www.w3.org/2001/XMLSchema#string

Therapeutic options for low bone mineral density in HIV-infected subjects.

about

P2860

P2860

Therapeutic options for low bone mineral density in HIV-infected subjects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698